The predominance of Ts cells in the CD8+T cells ultimately leads to a decrease or even inversion of the CD4+/CD8+ ratio, indicating dysfunction in the body’s immune function and compromised anti-tumor efficacy (Mamessier et al. 2011; Trédan et al. 2013). The gene discussed is CD8A; the disease is neoplasm.